greeksoup/ stock research
Stock research / United States / Funds / Bronte Capital Management Pty Ltd.

Bronte Capital Management Pty Ltd.

CIK 1471085 · latest 13F filed 5 August 2026 · Read the filing on EDGAR

Bronte Capital Management Pty Ltd. reported 56 US-listed holdings worth $888.3 million in its 13F for the quarter ended 30 June 2026, filed 5 August 2026. Its largest: Alphabet Inc. (12.3%), Regeneron Pharmaceuticals, Inc. (11.4%) and Interactive Brokers Group, Inc. (8.7%). Against the quarter before, it opened 15 positions, added to 7, trimmed 33 and sold out of 10.

Reported holdings$888.3M-5.6% on Q1 2026
Positions56+5 on Q1 2026
The largest ten74.4%of its reported holdings
Latest 13FQ2 2026filed 5 August 2026
Where the money is
Added toTrimmed
GOOGL12.3%REGN11.4%IBKR8.7%Visa8.5%BRKB8.2%AMZN7.0%PM6.1%CTVA4.4%COF3.9%DIS3.9%FCNCA3.3%TBBB2.5%AUR1.7%Vaneck1.6%42 more16.5%

The 14 largest of its 56 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $1.23 billion in 25 positions$1.23BQ3 24Q4 2024: $1.27 billion in 24 positions$1.27BQ4 24Q1 2025: $1.23 billion in 26 positions$1.23BQ1 25Q2 2025: $1.27 billion in 27 positions$1.27BQ2 25Q3 2025: $1.11 billion in 29 positions$1.11BQ3 25Q4 2025: $956.8 million in 43 positions$957MQ4 25Q1 2026: $940.9 million in 51 positions$941MQ1 26Q2 2026: $888.3 million in 56 positions$888MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +4.6% over the 2 quarters to 30 June 2026, against +9.5% for the S&P 500.

Its reported holdingsThe S&P 500
95100105110Q4 25Q1 26Q2 26Its holdings +4.6%S&P 500 +9.5%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 15Added 7Held 1Trimmed 33Sold out 10
Opened: 15Added: 7Held: 1Trimmed: 33Sold out: 10

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 15

  1. Brown Forman Corp. BFB$12.4 million
  2. Revolution Medicines, Inc. RVMD$3.5 million
  3. iShares Core S&P Small-Cap ETF IJR$3.4 million
  4. Tyler Technologies Inc. TYL$2.4 million
  5. Treace Med Concepts Inc. TMCI$61,996
  6. AN2 Therapeutics Inc. ANTX$52,732
  7. Alx Oncology Holdings Inc. ALXO$37,457
  8. Blend Labs Inc. BLND$32,912

and 7 more in the table below

Added to 7

  1. Walt Disney Co. DIS+174,566 shares · +94%
  2. BBB Foods Inc. TBBB+45,601 shares · +9%
  3. Global E Online Ltd GLBE+14,542 shares · +7%
  4. Riskified Ltd RSKD+99,770 shares · +20%
  5. Enovix Corporation ENVX+30,215 shares · +262%
  6. Milestone Pharmaceuticals Inc. (mist) MIST+3,976 shares · +38%
  7. C4 Therapeutics Inc. CCCC+316 shares · +3%

Trimmed 33

  1. Interactive Brokers Group, Inc. IBKR-398,205 shares · -31%
  2. Alphabet Inc. GOOGL-76,325 shares · -20%
  3. Herbalife Ltd HLF-616,540 shares · -66%
  4. Philip Morris International Inc. PM-40,922 shares · -12%
  5. Visa Inc-Class A Shares-19,456 shares · -8%
  6. Regeneron Pharmaceuticals, Inc. REGN-10,169 shares · -6%
  7. Amazon.com Inc. AMZN-24,306 shares · -9%
  8. First Citizens Bancshares Inc. FCNCA-2,313 shares · -14%

and 25 more in the table below

Sold out of 10

  1. Brown Forman Corp.$13.1 million last quarter
  2. iShares Trust IWO$11.8 million last quarter
  3. Pinterest, Inc. PINS$7.9 million last quarter
  4. Sally Beauty Holdings, Inc. SBH$3.1 million last quarter
  5. James Riv Group Ltd JRVR$2.1 million last quarter
  6. Caribou Biosciences Inc. CRBU$29,691 last quarter
  7. Pliant Therapeutics Inc. PLRX$23,452 last quarter
  8. Invivyd Inc. IVVD$14,316 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Alphabet Inc. GOOGL305.2K$109.1 million12.28%-76.3K
Regeneron Pharmaceuticals, Inc. REGN162.6K$101.4 million11.41%-10.2K
Interactive Brokers Group, Inc. IBKR883.5K$76.9 million8.66%-398.2K
Visa Inc-Class A Shares219.9K$75.5 million8.49%-19.5K
Berkshire Hathaway Inc. Class B BRKB145.8K$73.0 million8.22%-9.2K
Amazon.com Inc. AMZN261.4K$62.3 million7.01%-24.3K
Philip Morris International Inc. PM300.2K$54.3 million6.11%-40.9K
Corteva, Inc. CTVA456.7K$38.7 million4.35%-46.1K
Capital One Financial Corp. COF173.5K$34.8 million3.92%-13.8K
Walt Disney Co. DIS360.2K$34.7 million3.90%+174.6K
First Citizens Bancshares Inc. FCNCA14.2K$29.5 million3.32%-2.3K
BBB Foods Inc. TBBB533.2K$22.2 million2.50%+45.6K
Aurora Innovation, Inc. AUR2.2M$14.9 million1.68%-131.9K
Vaneck ETF Trust191.6K$14.5 million1.63%-16.5K
Sotera Health Co.797.1K$14.1 million1.59%-46.6K
Nektar Therapeutics NKTR198.4K$13.9 million1.56%+178
Graham Holdings Co. GHC11.5K$13.1 million1.47%-1.3K
iShares Trust IBB65.8K$12.5 million1.41%-3.5K
Brown Forman Corp. BFB464.3K$12.4 million1.39%new
Alnylam Pharmaceuticals, Inc. ALNY35.4K$10.7 million1.20%-1.9K
Sociedad Quimica Y Minera De SQM116.3K$8.6 million0.97%-6.1K
Global E Online Ltd GLBE227.6K$7.9 million0.89%+14.5K
Newmont Corp. NEM69.5K$6.5 million0.73%-5.9K
Barrick Mining Corp B146.4K$5.4 million0.61%-12.4K
LiveRamp Holdings, Inc. RAMP128.3K$4.8 million0.54%-94.9K
Herbalife Ltd HLF323.4K$4.3 million0.48%-616.5K
Revolution Medicines, Inc. RVMD18.8K$3.5 million0.40%new
Turning PT Brands Inc. TPB40.7K$3.5 million0.39%-2.1K
iShares Core S&P Small-Cap ETF IJR23.0K$3.4 million0.38%new
Bath & Body Works, Inc. BBWI143.8K$3.3 million0.37%-11.7K
Mondelez International, Inc. MDLZ53.2K$3.1 million0.35%-2.7K
Riskified Ltd RSKD588.3K$3.0 million0.33%+99.8K
Brown Forman Corp. BFA95.4K$2.6 million0.29%-5.0K
Tyler Technologies Inc. TYL8.3K$2.4 million0.27%new
Vaneck ETF Trust24.6K$2.4 million0.27%-2.0K
Paylocity Holding Corp. PCTY17.9K$1.9 million0.21%-18.7K
Nice Ltd NICE16.4K$1.5 million0.17%-695
Universal Display Corp. OLED10.3K$889,1930.10%-852
Verisk Analytics, Inc. VRSK2.7K$481,4990.05%-220
Enovix Corporation ENVX41.8K$92,9000.01%+30.2K
Treace Med Concepts Inc. TMCI15.6K$61,9960.01%new
Fate Therapeutics Inc. FATE21.7K$58,6980.01%-1.1K
AN2 Therapeutics Inc. ANTX10.9K$52,7320.01%new
C4 Therapeutics Inc. CCCC10.3K$48,3300.01%+316
Alx Oncology Holdings Inc. ALXO18.1K$37,4570.00%new
Blend Labs Inc. BLND19.2K$32,9120.00%new
Pepgen Inc. PEPG17.8K$31,9970.00%new
Bigcommerce Hldgs Inc. CMRC10.3K$30,4230.00%new
Pacific Biosciences Calif in PACB17.9K$30,0400.00%new
Acumen Pharmaceuticals Inc. ABOS10.7K$28,6120.00%new
Seer Inc. SEER15.1K$25,0810.00%new
Alector Inc. ALEC11.8K$23,6340.00%-7.5K
I Mab NBP11.2K$21,8240.00%new
Coherus Biosciences Inc. CHRS15.3K$21,3670.00%-4.0K
Milestone Pharmaceuticals Inc. (mist) MIST14.4K$19,2830.00%+4.0K
Gossamer Bio, Inc. GOSS67.8K$11,1520.00%new
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 10 it sold out of are in the box above.

Options it reported

CompanyOptionShares under the optionsValue of those shares
Regeneron Pharmaceuticals, Inc. REGNCalls68.6K$42.8 million

1 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.